Suchergebnisse - "Malek, Thomas R"

PubPharm (163)

1

Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer

enthalten in: Immunity | 2024

von Shouse, A. | LaPorte, K. | Malek, T.

2

Immunotherapy With Low-Dose IL-2/CD25 Prevents β-Cell Dysfunction and Dysglycemia in Prediabetic NOD Mice

enthalten in: Diabetes | 2023

von Qureshi, F. | Panzer, J. | Põder, J. | +2

3

Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8+ T cells

enthalten in: Journal for immunotherapy of cancer | 2023

von LaPorte, K. | Hernandez, R. | Santos Savio, A. | +1

4

Regulatory T Cell Amelioration of Graft-versus-Host Disease following Allogeneic/Xenogeneic Hematopoietic Stem Cell Transplantation Using Mobilized Mouse and Human Peripheral Blood Donors

enthalten in: Transplantation and cellular therapy | 2023

von Barreras, H. | Copsel, S. | Bader, C. | +14

5

Engineering IL-2 for immunotherapy of autoimmunity and cancer

enthalten in: Nature reviews. Immunology | 2022

von Hernandez, R. | Põder, J. | LaPorte, K. | +1

6

Dynamic transcriptional activity and chromatin remodeling of regulatory T cells after varied duration of interleukin-2 receptor signaling

enthalten in: Nature immunology | 2022

von Moro, A. | Gao, Z. | Wang, L. | +7

7

Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity

enthalten in: Frontiers in oncology | 2022

von Hernandez, R. | Malek, T.

8

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity

enthalten in: Journal for immunotherapy of cancer | 2021

von Hernandez, R. | LaPorte, K. | Hsiung, S. | +2

9

Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus Erythematosus

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2021

von Xie, J. | Zhang, Y. | Loubeau, M. | +13

CommentOn: J Immunol. 2021 Jul 1;207(1):1-2. - PMID 34935627

10

Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity

enthalten in: Cancer immunology, immunotherapy : CII | 2021

von Hernandez, R. | Toomer, K. | Põder, J. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]